FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Report suggests a big improvement in lung cancer survival

2.

Study reveals link between new-onset type 2 diabetes and some obesity-related cancers

3.

If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version

4.

Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?

5.

Research uncovers hidden Australian skin cancer epidemic


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot